Enlivex Therapeutics Ltd.

General ticker "ENLV" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $24.4M (TTM average)

Enlivex Therapeutics Ltd. follows the US Stock Market performance with the rate: 5.9%.

Estimated limits based on current volatility of 4.7%: low 0.80$, high 0.89$

Factors to consider:

  • Total employees count: 11 as of 2014
  • Price in estimated range
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [0.69$, 1.60$]
  • 2026-12-31 to 2027-12-31 estimated range: [0.77$, 1.73$]

Financial Metrics affecting the ENLV estimates:

  • Positive: with PPE of 0.0 at the end of fiscal year the price was low
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -29.25 <= 0.07
  • Positive: Interest expense per share per price, % of 0.04 <= 0.73
  • Positive: Return on assets ratio (scaled to [-100,100]) of 34.68 > 6.12
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: negative Industry operating cash flow (median)
  • Positive: Inventory ratio change, % of 0 <= 0

Similar symbols

Short-term ENLV quotes

Long-term ENLV plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $29.39MM $15.54MM $15.00MM
Operating Income $-29.39MM $-15.54MM $-15.00MM
Non-Operating Income $0.33MM $0.52MM $1,633.17MM
Interest Expense $0.01MM $0.01MM $0.01MM
R&D Expense $19.23MM $10.13MM $8.92MM
Income(Loss) $-29.07MM $-15.01MM $1,618.17MM
Taxes $0.00MM $0.00MM $382.65MM
Profit(Loss)* $-29.07MM $-15.01MM $1,235.53MM
Stockholders Equity $30.08MM $23.59MM $1,934.95MM
Assets $36.83MM $27.69MM $2,327.00MM
Operating Cash Flow $-23.52MM $-13.01MM $-10.42MM
Capital expenditure $0.24MM $0.10MM $0.07MM
Investing Cash Flow $-25.97MM $9.06MM $-1.32MM
Financing Cash Flow $0.36MM $6.45MM $10.38MM
Earnings Per Share** $-1.56 $-0.73 $27.04

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.